Paul Kalra is Consultant Cardiologist at Portsmouth NHS Trust, UK. He has championed local heart failure services; developing an integrated team across primary and secondary care (local population approximately 650,000) and co-leads the tertiary centre complex device service (ICD and CRT implantation). He has developed and leads a cardiovascular research programme in Portsmouth.
Paul is Chair Elect of the British Society for Heart Failure (Chair commences November 2017). He was Programme Co-director of the Annual Scientific meeting in 2010, 2013 and 2016, and the Training/Revalidation meeting in 2010, 2011 and 2015.
He has a clinical and research interest in cardiorenal disease. He co-founded the Cardiorenal Forum, which will hold its 12th annual meeting in October 2017. This is primarily an education meeting but it also has been successful in bringing together research expertise from nephrologists and cardiologists contributing to the development of important studies.
Paul Kalra is Chief Investigator for the British Heart Foundation funded ‘Effectiveness of Intravenous iron treatment vs standard care in
patients with heart failure and iron deficiency: a randomized, open-label multicentre trial (IRONMAN)’. This is a UK interventional study of intravenous iron in chronic heart failure that will recruit 1300 patients across 80 sites with the primary endpoint of cardiovascular mortality or recurrent hospitalisation for worsening heart failure